induced-pluripotent-stem-cells
(2)
I Peace, Inc.
I Peace, Inc. is a Palo Alto- and Kyoto-based biotech that mass-manufactures clinical-grade induced pluripotent stem cells (iPSCs) using a proprietary automated, closed-cassette platform. Founded in 2015 by Koji Tanabe - a co-author of the world's first human iPSC paper from Shinya Yamanaka's Nobel Prize-winning lab - the company operates as a CDMO supplying GMP-grade iPSCs to pharmaceutical companies, biotechs, and research institutions, and offers personal iPSC banking and longevity services that aim to make cell therapy affordable and accessible.
Koji Tanabe
Koji Tanabe is the founder and CEO of I Peace, Inc., a Palo Alto and Kyoto biotech building an automated platform to mass-manufacture clinical-grade induced pluripotent stem cells (iPSCs). He earned his PhD in the Kyoto University lab of Nobel laureate Shinya Yamanaka and was a co-author of the landmark paper that first reported the creation of human iPS cells. After postdoctoral work at Stanford, he founded I Peace in 2015 with the goal of giving every person access to their own stem cells for therapy and longevity.